Financials
Financial year 2025
DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN from Evergem, company number BE0892402176, closed financial year 2025 with a result of € 316,827 after tax. For that financial year DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN recorded a gross margin of € 450,094 and equity of € 1 million. Compared with financial year 2024, the result moved from € 290,805 to € 316,827. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ 1 million
▼ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 316,827
▲ 9% vs 2024
Profit after tax over the fiscal year.
€ 257,630
▲ 44% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 337,612 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 49,200
▲ € 37,832 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,275
Supplier invoices still open on the last day of the fiscal year.
€ 10,178
▼ 94% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 351,658 | € 382,280 | € 454,799 | € 450,094 | ▼ 1% |
| Profit after taxes | € 242,696 | € 257,813 | € 290,805 | € 316,827 | ▲ 9% |
| Equity | € 624,466 | € 882,279 | € 1,022,759 | € 1,001,974 | ▼ 2% |
| Total debts | € 134,879 | € 64,314 | € 161,187 | € 275,645 | ▲ 71% |
| Cash | € 496,122 | € 74,205 | € 178,654 | € 257,630 | ▲ 44% |
| Land & buildings | € 3,330 | € 2,632 | € 1,933 | € 1,235 | ▼ 36% |
| Retained profit | € 464,466 | € 722,279 | € 862,759 | € 997,263 | ▲ 16% |
| Dividend | € 110,138 | € 0 | € 150,324 | € 337,612 | ▲ 125% |
| Balance sheet total | € 759,345 | € 946,592 | € 1,183,946 | € 1,277,619 | ▲ 8% |
Key figures of DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN?
What happened at DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 316,827 (▲ 9% vs 2024). Source: NBB ↗
- Bart Sierens became a director. NBB
- Kristin Jacobs became a director. NBB
- New establishment in Eeklo. KBO
- New establishment in Evergem. KBO
- Start of the company according to the CBE. KBO
In short
From € 242,696 profit in 2022 to € 316,827 profit in 2025.
Paid € 526,520 in corporate taxes since 2022.
Best year ever: 2025, with € 316,827 profit.
Paid out € 598,074 in dividends to the owners in total.
A new publication or filing at DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN? We notify you, reason included.
Follow DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTENDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN are Bart Sierens and Kristin Jacobs.
Directors
According to the 2025 annual accounts
Bart Sierens
Director
since 2022
Kristin Jacobs
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Keizersdreef 15
9940 Evergem
Weststraat 4
9940 Evergem
Active since 20 October 2010
Ringlaan 15
9900 Eeklo
Active since 1 April 2017
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0892.402.176
- VAT number
- BE 0892.402.176
- Registered office
- Keizersdreef 15, 9940 Evergem
- Names & denominations
- DR. B. SIERENS, INWENDIGE ZIEKTEN - DR. K. JACOBS, OOGZIEKTEN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 September 2007
- Peppol
- Active · Active since 10 Dec 2025
- Contact
- [email protected] 0486513506
- Activities · NACE
Activiteiten van medisch specialisten